a month ago
RLAY
AnalystsBradley CaninoBradley Canino's Stock Forecasts
AnalystsBradley Canino
Sectors:
Analyst Ranking
Top 17%
#887 out of 5253 analysts
Average Return
+7.81%
Win Rate
43%50 out of 117
Risk vs Reward
Poor
Good
Bradley Canino's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | +441.18% | $3.74 | $20.24 | 2024-03-25 - 2025-03-25 | Strong Buy |
Relay Therapeutics IncRLAY | +302.75% | $4.00 | $16.11 | 2025-09-03 - 2026-04-16 | Strong Buy |
Celcuity IncCELC | +229.04% | $15.77 | $51.89 | 2024-08-14 - 2025-08-14 | Strong Buy |
Celcuity IncCELC | +213.06% | $15.27 | $47.81 | 2024-10-06 - 2025-10-06 | Strong Buy |
Relay Therapeutics IncRLAY | +181.85% | $3.25 | $9.16 | 2025-02-26 - 2026-02-26 | Strong Buy |
Bradley Canino Analyst Color
Get additional color on Bradley Canino's coverage of popular stocks
2 months ago
DMRA
4 months ago
DMRA
5 months ago
NUVL
2 years ago
SMMT
2 years ago
NUVL
2 years ago
SMMT
2 years ago
MRUS
2 years ago
CCCC
Bradley Canino's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tyra Biosciences IncTYRA | 1 | Strong Buy | $54.00 | +53.76% | Initiates Coverage On | 2 days ago |
Pyxis Oncology IncPYXS | 4 | Strong Buy | $8.00 | +370.59% | Maintains | 24 days ago |
Olema Pharmaceuticals IncOLMA | 2 | Strong Buy | $38.00 | +130.58% | Maintains | a month ago |
Relay Therapeutics IncRLAY | 7 | Strong Buy | $22.00 | +36.56% | Maintains | a month ago |
Janux Therapeutics IncJANX | 6 | Strong Buy | $68.00 | +347.66% | Maintains | 2 months ago |
Damora Therapeutics IncDMRA | 3 | Strong Buy | $40.00 | +48.15% | Maintains | 2 months ago |
Cullinan Therapeutics IncCGEM | 3 | Strong Buy | $30.00 | +103.53% | Initiates Coverage On | 2 months ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $35.00 | +79.95% | Initiates Coverage On | 3 months ago |
Nuvalent IncNUVL | 5 | Strong Buy | $155.00 | +49.24% | Maintains | 5 months ago |
Kymera Therapeutics IncKYMR | 5 | Strong Buy | $90.00 | +4.48% | Assumes | 5 months ago |
Summit Therapeutics IncSMMT | 6 | Strong Buy | $40.00 | +63.80% | Reiterates | 6 months ago |
Cg Oncology IncCGON | 1 | Strong Buy | $90.00 | +35.66% | Initiates Coverage On | 6 months ago |
Celcuity IncCELC | 5 | Strong Buy | $110.00 | -12.18% | Initiates Coverage On | 7 months ago |
Syndax Pharmaceuticals IncSNDX | 7 | Strong Buy | $44.00 | +84.80% | Reinstates | 7 months ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $18.00 | +75.95% | Assumes | 7 months ago |
C4 Therapeutics IncCCCC | 5 | Strong Buy | $8.00 | +175.86% | Initiates Coverage On | 7 months ago |
Black Diamond Therapeutics IncBDTX | 6 | Strong Buy | $8.00 | +173.97% | Initiates Coverage On | 7 months ago |
Alx Oncology Holdings IncALXO | 7 | Hold | $1.50 | N/A | Maintains | a year ago |
Arvinas IncARVN | 6 | Strong Buy | $51.00 | N/A | Maintains | a year ago |
Affimed NvAFMDQ | 6 | Hold | $4.00 | N/A | Maintains | a year ago |
Kura Oncology IncKURA | 6 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
Zentalis Pharmaceuticals IncZNTL | 17 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Merus NvMRUS | 7 | Strong Buy | $99.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 6 | Strong Buy | $130.00 | N/A | Maintains | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 6 | Strong Buy | $23.00 | N/A | Maintains | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Turning Point Therapeutics IncTPTX | 2 | Hold | $45.00 | N/A | Maintains | 4 years ago |
Mersana Therapeutics IncMRSN | 1 | Hold | $450.00 | N/A | Initiates Coverage On | 5 years ago |
Seagen IncSGEN | 1 | Hold | $145.00 | N/A | Initiates Coverage On | 5 years ago |
Zymeworks IncZYME | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 5 years ago |
Epizyme IncEPZM | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 5 years ago |
Exelixis IncEXEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.